Management of bacterial urinary tract infections in adult patients with diabetes mellitus

Drugs

Volumn 62, Issue 13, 2002, Pages 1859-1868

  Meiland, Ruby ^a   Geerlings, Suzanne E ^b   Hoepelman, Andy I M ^a,c  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; CYTOKINE; ESTROGEN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; UROVAC; VACCINE;

ADULT; BACTERIUM ADHERENCE; BACTERIURIA; CLINICAL FEATURE; CYSTITIS; CYTOKINE RELEASE; DIABETES MELLITUS; DRUG EFFICACY; FEMALE; FLUID INTAKE; HUMAN; HYPOGLYCEMIA; LACTOBACILLUS; MALE; MICTURITION; PREVALENCE; PYELONEPHRITIS; RECURRENCE RISK; REVIEW; RISK FACTOR; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); LACTOBACILLUS;

EID: 0036384290     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200262130-00003     Document Type: Review

References (72)

1. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997 Sep; 11 (3): 551-81
2. Barnett BJ, Stephens DS. Urinary tract infection: an overview. Am J Med Sci 1997 Oct; 314 (4): 245-9
3. Johnson JR, Roberts PL, Stamm WE. P fimbriae and other virulence factors in Escherichia coli urosepsis: Association with patients' characteristics. J Infect Dis 1987 Jul; 156 (1): 225-9
4. Hoepelman AIM, Van Buren M, Van den Broek PJ, et al. Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count). AIDS 1992; 6 (2): 179-84
5. Carton JA, Maradona JA, Nuno FJ, et al. Diabetes mellitus and bacteraemia: A comparative study between diabetic and non-diabetic patients. Eur J Med 1992 Jul; 1 (5): 281-7
6. Baldwin AD, Root HF. Infections of the upper urinary tract in the diabetic patient. N Engl J Med 1940 Aug 15; 223 (7): 244-50
7. Zhanel GG, Harding GK, Nicolle LE. Asymptomatic bacteriuria in patients with diabetes mellitus. Rev Infect Dis 1991; 13 (1): 150-4
8. Geerlings SE, Stolk RP, Camps MJL, et al. Asymptomatic bacteriuria may be considered a complication in women with diabetes. Diabetes Care 2000 May; 23 (6): 744-9
9. Forland M, Thomas V, Shelokov A. Urinary tract infections in patients with diabetes mellitus. Studies on antibody coating of bacteria. JAMA 1977 Oct 31; 238 (18): 1924-6
10. Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 1997 Sep; 11 (3): 735-50
11. Nicolle LE, Friesen D, Harding GK, et al. Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992; impact of diabetes, pregnancy, and aboriginal origin. Clin Infect Dis 1996 Jun; 22 (6): 1051-6
12. Wheat LJ. Infection and diabetes mellitus. Diabetes Care 1980 Jan; 3 (1): 187-97
13. Sobel J.D., Kaye D., Urinary tract infections. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995: 662-90
14. Podschun R, Sievers D, Fischer A, et al. Serotypes, hemaglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections. J Infect Dis 1993 Dec; 168 (6): 1415-21
15. Mulvey MA, Schilling JD, Martinez JJ, et al. Bad bugs and beleaguered bladders: Interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A 2000 Aug 1; 97 (16): 8829-35
16. Geerlings SE, Brouwer EC, Gaastra W, et al. Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals. J Med Microbiol 1999; 48 (6): 535-9
17. Geerlings SE, Stolk RP, Camps MJL, et al. Risk factors for symptomatic urinary tract infection in women with diabetes mellitus. Diabetes Care 2000 Dec; 23 (12): 1737-41
18. Geerlings SE, Brouwer EC, Van Kessel KCPM, et al. Cytokine secretion is impaired in women with diabetes mellitus. Eur J Clin Invest 2000 Nov; 30 (11): 995-1001
19. Geerlings SE, Meiland R, Van Lith EC, et al. Adherence of type 1-fimbriated Escherichia coli to uroepithelial cells: more in diabetic women than in controls. Diabetes Care 2002 Aug; 25 (8): 1405-9
20. Kinane DF, Blackwell CC, Brettle RP, et al. ABO blood group, secretor state, and susceptibility to recurrent urinary tract infection in women. BMJ 1982; 285: 7-9
21. Scholes D, Hooton TM, Roberts PL, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000 Oct; 182 (4): 1177-82
22. Delamaire M, Maugendre D, Moreno M, et al. Impaired leucocyte functions in diabetic patients. Diabet Med 1997; 14 (1): 29-34
23. Balasoiu D, Van Kessel KC, Van Kats-Renaud HJ, et al. Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care 1997 Mar; 20 (3): 392-5
24. Wang QN, Qiu ZD. Infection in acute leukemia: an analysis of 433 episodes. Rev Infect Dis 1989 Nov; 11 Suppl. 7: S1613-20
25. Luster AD. Chemokines - Chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338 (7): 436-45
26. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 2001 Jul; 69 (7): 4572-9
27. Geerlings SE, Brouwer EC, Gaastra W, et al. Is a second urine necessary for the diagnosis of asymptomatic bacteriuria? Clin Infect Dis 2000; 31 (3): E3-4
28. Zhanel GG, Nicolle LE, Harding GKM, et al. Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. Clin Infect Dis 1995 Aug; 21 (2): 316-22
29. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med 1993 Oct 28; 329 (18): 1328-34
30. Geerlings SE, Stolk RP, Camps MJL, et al. Consequences of asymptomatic bacteriuria in women with diabetes mellitus. Arch Intern Med 2001 Jun 11; 161 (11): 1421-7
31. Frimodt-MØller C. Diabetic estopathy: epidemiology and related disorders. Ann Intern Med 1980; 92 (2 Pt 2): 318-21
32. Vejlsgaard R. Studies on urinary infection in diabetics. II Significant bacteriuria in relation to long-term diabetic manifestations. Acta Med Scand 1966; 179: 183-8
33. Nicolle LE. A practical guide to antimicrobial management of complicated urinary tract infection. Drugs Aging 2001; 18 (4): 243-54
34. Lye WC, Chan RKT, Lee EJC, et al. Urinary tract infections in patients with diabetes mellitus. J Infect 1992; 24: 169-74
35. Johnson JR, Stamm WE. Urinary Tract Infections in Women: Diagnosis and Treatment. Ann Intern Med 1989 Dec 1; 111 (11): 906-17
36. Hooton TM, Scholes D, Stapleton AE, et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 2000 Oct 5; 343 (14): 992-7
37. Ronald AR, Patullo LS. The natural history of urinary infections in adults. Infect Dis Clin North Am 1991 Mar; 75 (2): 299-312
38. Stein G, Funfstuck R. Asymptomatic bacteriuria-what to do. Nephrol Dial Transplant 1999; 14 (7): 1618-21
39. Zhanel GG, Harding GKM, Guay DRP. Asymptomatic bacteriuria. Which patients should be treated? Arch Intern Med 1990 Jul; 150 (7): 1389-96
40. Nelson RG, Knowler WC, Pettitt DJ, et al. Kidney diseases in diabetes. In: National Diabetes Data Group, editors. Diabetes in America. Bethesda (MD): National Institutes of Health, 1995: 349-401
41. Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999 Oct 7; 341 (15): 1127-33
42. Forland M, Thomas VL. The treatment of urinary tract infections in women with diabetes mellitus. Diabetes Care 1985 Sep; 8 (5): 499-506
43. Calvet HM, Yoshikawa TT. Infections in diabetes. Infect Dis Clin North Am 2001 Jun; 15 (2): 407-21
44. Saiki J, Vaziri ND, Barton C. Perinephric and intranephric abscesses: a review of the literature. West J Med 1982 Feb; 136 (2): 95-102
45. Ronald AR, Harding GKM. Complicated urinary tract infections. Infect Dis Clin North Am 1997; 11 (3): 583-93
46. Ronald A, Ludwig E. Urinary tract infections in adults with diabetes. Int J Antimicrob Agents 2001 Apr; 17 (4): 287-92
47. Melekos MD, Naber KG. Complicated urinary tract infections. Int J Antimicrob Agents 2000 Aug; 15 (4): 247-56
48. Nicolle LE. Asymptomatic bacteriuria in diabetic women. Diabetes Care 2000 Jul; 23 (6): 722-3
49. Deresinski S. Infections in the diabetic patient: Strategies for the clinician. Infectious Disease Reports 1995 Jan; 1 (1): 1-12
50. Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999 Oct; 29 (4): 745-58
51. Poretsky L, Moses AC. Hypoglycemia associated with trimethoprim/sulfamethoxazole therapy. Diabetes Care 1984 Sep; 7 (5): 508-9
52. Veyssier P, Botto H, Jean C, et al. 5 Day- versus 10 Day-Ofloxacin (OFL) treatment in complicated lower urinary tract infections (LUTI) in women (W) [abstract no. L1057]. Proceedings of the 41th Interscience Congress on Antimicrobial Agents and Chemotherapy; 2001 Dec 16-19, Chicago (IL)
53. Schaeffer AJ. Bacterial urinary tract infections in diabetes [editorial comment]. J Urol 1998 Jul; 160 (1): 293
54. Raz R, Naber KG, Raizenberg C, et al. Ciprofloxacin 250 mg twice daily versus ofloxacin 200 mg twice daily in the treatment of complicated urinary tract infections in women. Eur J Clin Microbiol Infect Dis 2000 May; 19 (5): 327-31
55. Rubin RH, Shapiro ED, Andriole VT, et al. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect Dis 1992; 15 Suppl. 1: S216-27
56. Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial. JAMA 2000 Mar 22; 283 (12): 1583-90
57. Chen MT, Huang CN, Chou YH, et al. Percutaneous drainage in the treatment of emphysematous pyelonephritis: 10-year experience. J Urol 1997 May; 157 (5): 1569-73
58. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA 1999 Feb 24; 281 (8): 736-8
59. Stapleton A, Stamm WE. Prevention of urinary tract infection. Infect Dis Clin North Am 1997 Sep; 11 (3): 719-33
60. Nicolle LE. Prevention and treatment of urinary catheter-related infections in older patients. Drugs Aging 1994; 4 (5): 379-91
61. Kontiokari T, Sundqvist K, Nuutinen M, et al. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001 Jun 30; 322 (7302): 1571-3
62. Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther 1992 Jan; 14 (1): 11-6
63. Hextall A. Oestrogens and lower urinary tract function. Maturitas 2000 Aug 31; 36 (2): 83-92
64. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infection. N Engl J Med 1993; 329 (11): 753-6
65. Brown JS, Vittinghoff E, Kanaya AM, et al. Urinary tract infections in postmenopausal women: effect of hormone therapy and risk factors. Obstet Gynecol 2001 Dec; 98 (6): 1045-1052
66. Uehling DT, Hopkins WJ, Beierle LM, et al. Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial. J Infect Dis 2001 Mar 1; 183 Suppl. 1: S81-3
67. Langermann S, Mollby R, Burlein JE, et al. Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli. J Infect Dis 2000 Feb; 181 (2): 774-8
68. Meiland R, Geerlings SE, Brouwer EC, et al. Adherence of Escherichia coli to uroepithelial cells of women with diabetes mellitus (DM) can be inhibited by vaccine-induced anti-FimCH antiserum [abstract no. L1349]. Proceedings of the 41th Interscience Congres on Antimicrobial Agents and Chemotherapy; 2001 Dec 16-19; Chicago (IL)
69. Lowe FC, Fagelman E. Cranberry juice and urinary tract infections: What is the evidence? Urology 2001 Mar; 57 (3): 407-13
70. Boris S, Suarez JE, Vazquez F, et al. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 1998 May; 66 (5): 1985-9
71. Langermann S, Palaszynski S, Barnhart M, et al. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 1997 Apr 25; 276 (5312): 607-11
72. Golden SH, Peart-Vigilance C, Kao WH, et al. Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes. Diabetes Care 1999 Sep; 22 (9): 1408-14